Expertise in
14
conditions

Fadi Fakhouri

Lausanne, VD, CH 
Expertise in
14
conditions
Lausanne, VD, CH 

Overview

Fadi Fakhouri practices practicing medicine in Lausanne, Switzerland.

Mr. Fakhouri is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Atypical Hemolytic Uremic Syndrome (aHUS), D-Minus Hemolytic Uremic Syndrome, D-Plus Hemolytic Uremic Syndrome, Hemolytic-Uremic Syndrome, and Kidney Transplant.

He is actively involved in clinical research, co-authoring 143 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Lausanne, VD, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease: a Prospective, Multicenter, Randomized, Open-label, Clinical Trial
Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease: a Prospective, Multicenter, Randomized, Open-label, Clinical Trial
Enrollment Status: Active_not_recruiting
Publish Date: March 20, 2026
Intervention Type: Other, Drug
Study Phase: Phase 3
Multicentric, Prospective Open-label Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With Atypical Hemolytic Uremic Syndrome (aHUS)
Multicentric, Prospective Open-label Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With Atypical Hemolytic Uremic Syndrome (aHUS)
Enrollment Status: Completed
Publish Date: December 06, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

143 Total Publications

Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN. Reply.
Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN. Reply.
Journal: The New England journal of medicine
Published: March 11, 2026

Frequently Asked Questions about Fadi Fakhouri

Is Fadi Fakhouri a top-rated expert for Atypical Hemolytic Uremic Syndrome (aHUS)?

MediFind is an objective health platform that identifies experts based on real-world data. Fadi Fakhouri is classified as an Elite expert for Atypical Hemolytic Uremic Syndrome (aHUS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Fadi Fakhouri participate in research or clinical trials?

Yes. Fadi Fakhouri has published 143 articles and abstracts on conditions like Atypical Hemolytic Uremic Syndrome (aHUS). You can view a list of Fadi Fakhouri's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Fakhouri's expertise for a condition
ConditionClose
View All 27 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile